Arbor Rapha Capital Bioholdings I ^{Priced, Nasdaq: ARCKU}

We are a newly organized blank check company. While we may pursue an acquisition opportunity in any industry or sector, we intend to capitalize on our management team’s experience and expertise to identify attractive acquisition opportunities in the biopharmaceutical sector, with a focus on disruptive technologies with the potential to transform healthcare and dramatically improve the lives of patients. Our sponsor is a newly formed Delaware limited liability company. We believe our ability to complete our initial business combination will be enhanced by our sponsor’s affiliation with Rapha Capital Management, LLC (“RCM”) and RNA Advisors, LLC, doing business as RNA Capital Advisors (“RNA”). RCM is an investment management firm located in Miami, Florida focused on identifying and managing strategic investments in early stage, non-public biotechnology companies, with a strategy of identifying and growing revolutionary and disruptive ideas in medicine, healthcare, and biotechnology before others can see their value. RNA is a financial, strategic and transaction advisory services firm which focuses almost exclusively on life sciences and healthcare technology.